Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Post-transplant bronchiolitis obliterans.

A Boehler1, M Estenne

  • 1Division of Pulmonary Medicine, University Hospital, Zurich, Switzerland.

The European Respiratory Journal
|December 19, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hepatitis From Spiroplasma sp. in an Immunocompromised Patient.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

Detection of pulmonary amylase activity in exhaled breath condensate.

Journal of breath research·2013
Same author

Cyclosporine A drives a Th17- and Th2-mediated posttransplant obliterative airway disease.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013
Same author

Percutaneous endoscopic jejunostomy in patients with gastroparesis following lung transplantation: feasibility and clinical outcome.

Endoscopy·2012
Same author

Bilateral lung transplantation for pediatric idiopathic pulmonary arterial hypertension: a multi-center experience.

Pediatric pulmonology·2011
Same author

[Medical complications of lung transplantation].

Revue de pneumologie clinique·2011
Same journal

Decoding the Lymphangioleiomyomatosis (LAM) Niche Microenvironment <i>via</i> Integrative Analysis of Single Cell Multiomics and Spatial Transcriptomics.

The European respiratory journal·2026
Same journal

ERS Statement on ultrasound guided interventions in respiratory disease.

The European respiratory journal·2026
Same journal

When symptoms and resting tests disagree in interstitial lung disease: a selective role for cardiopulmonary exercise testing.

The European respiratory journal·2026
Same journal

Clinical Practice Guideline for the diagnosis of Granulomatous-Lymphocytic Interstitial Lung Disease (GLILD) in patients with Common Variable Immunodeficiency Disorders (CVID) - an ERS Clinical Research Collaboration.

The European respiratory journal·2026
Same journal

SARS-CoV-2 (E)-protein induces rapid TLR2-mediated T cell activation in mouse lungs revealed by intravital lung microscopy.

The European respiratory journal·2026
Same journal

Functional characterization of <b><i>KCNA5</i></b> gene variants linked to pulmonary arterial hypertension.

The European respiratory journal·2026
See all related articles

Lung transplantation survival has improved, but bronchiolitis obliterans remains a major threat. This review covers risk factors, pathogenesis, and prevention strategies for this common complication.

Area of Science:

  • Medicine
  • Immunology
  • Pulmonology

Background:

  • Lung transplantation outcomes have improved due to advances in surgical techniques, preservation, immunosuppression, and complication management.
  • Bronchiolitis obliterans syndrome (BOS) is a primary cause of chronic allograft dysfunction, significantly impacting long-term survival and quality of life post-transplant.
  • BOS affects 50-60% of patients surviving 5 years and contributes to over 30% of late post-operative deaths.

Purpose of the Study:

  • To review the current understanding of bronchiolitis obliterans after lung transplantation.
  • To discuss alloimmune-dependent and -independent risk factors for BOS development.
  • To explore pathogenesis, clinical staging, prevention, and early detection strategies for BOS.

Main Methods:

Related Experiment Videos

  • Review of existing literature on lung transplantation and bronchiolitis obliterans.
  • Analysis of findings from animal and human studies on BOS pathogenesis.
  • Discussion of clinical staging and management strategies.

    • Main Results:

    • Intermediate-term survival after lung transplantation is now achievable.
    • Bronchiolitis obliterans remains a significant challenge, affecting long-term graft survival and patient quality of life.
    • Both immune and non-immune factors contribute to BOS development.

    Conclusions:

    • Despite advances, bronchiolitis obliterans remains a critical barrier to long-term lung transplant success.
    • Further research into risk factors, pathogenesis, and effective prevention/detection strategies is essential.
    • Addressing BOS is crucial for improving outcomes for lung transplant recipients.